CSPAN Key Capitol Hill Hearings May 1, 2015
Between basic research and Clinical Research all the way from the time of concept to the time of actually getting in the marketplace what are the key factors that you see thats increasing the cost more than anything else . And i know its not only one thing but if you can give me a couple things here what we should watch for. A lot of it is the high failure rate and that is in fact very troubling when you consider how rarely an idea about a new drug makes it all the way through to f. D. A. Approval its less than 1 of the time. So all that cost of the failures has to be added into the overall en...